Peter van de Ven

Associate Professor

University Medical Center Utrecht, Utrecht University

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Cancer Research Cancer Research professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Peter van de Ven is an Associate Professor at the University Medical Center Utrecht in the Netherlands. His research focuses on treatment implementation for rare diseases, colorectal cancer therapy, and clinical trial design, particularly in the context of novel statistical approaches. Recent articles highlight his work on preventing respiratory syncytial virus infection in preterm infants and the effectiveness of L-serine supplementation in specific genetic conditions.

Articles (9)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Sander van Doorn

University Medical Center Groningen

NETHERLANDS

View details

Martina Cornel

Professor of Community Genetics and Public Health Genomics

Amsterdam UMC Locatie VUmc

NETHERLANDS

View details

Menno Huisman

professor of medicine

Leiden University Medical Center

NETHERLANDS

View details

Gabor Liposits

Aarhus University

DENMARK

View details

Huiberdina L. Koek

University Medical Center Groningen

NETHERLANDS

View details

Melchior Nierman

Chief Medical Officer

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter van de Ven

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Overcoming treatment implementation barriers for individuals with rare diseases using single-case experimental designs

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase 3 CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group

Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial

Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials

Daily intranasal palivizumab to prevent respiratory syncytial virus infection in healthy preterm infants: a phase 1/2b randomized placebo-controlled trial

A Bayesian-adaptive decision-theoretic approach can reduce the sample sizes for multiarm exercise oncology trials

Comparing the sensitivities of two screening tests in nonblinded randomized paired screen‐positive trials with differential screening uptake

Bayesian adaptive decision-theoretic designs for multi-arm multi-stage clinical trials

Evolution of coronary artery calcium and absolute myocardial perfusion after percutaneous revascularization: A 3-year serial hybrid [15O]H2O PET/CT imaging study

Collaborators (6)

Sander van Doorn

Martina Cornel

Menno Huisman

Gabor Liposits

Huiberdina L. Koek

Melchior Nierman

Make your next move.